Indivior ( (GB:INDV) ) has issued an update.
Indivior PLC announced that Daniel Ninivaggi, a Non-Executive Director, acquired 15,000 ordinary shares of the company at an average price of $8.78 per share. This transaction, conducted on February 27, 2025, on the Nasdaq Global Select Market, reflects a significant personal investment by a key member of the company’s board, potentially indicating confidence in the company’s future performance.
More about Indivior
Indivior PLC operates in the pharmaceutical industry, focusing on the development and commercialization of medications for the treatment of addiction and its co-occurring disorders. The company is known for its expertise in addiction treatment and aims to provide innovative solutions to improve patient outcomes.
YTD Price Performance: -31.64%
Average Trading Volume: 307,400
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £871.1M
For an in-depth examination of INDV stock, go to TipRanks’ Stock Analysis page.